M

Milestone Pharmaceuticals
D

MIST

1.90000
USD
0.02
(0.80%)
مغلق
حجم التداول
18,628
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
223,567,826
المقالات
المزيد

العنوان: Milestone Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.